Long‐term outcomes of relapsed/refractory double‐hit lymphoma (r/r DHL) treated with CD19/22 CAR T‐cell cocktail therapy

Long‐term outcomes of relapsed/refractory double‐hit lymphoma (r/r DHL) treated with CD19/22 CAR T‐cell cocktail therapy

Bibliographic Details
Main Authors: Jia Wei, Zekai Mao, Na Wang, Lifang Huang, Yang Cao, Weimin Sun, Xiaolu Long, Jiaqi Tan, Chunrui Li, Yi Xiao, Chaojiang Gu, Shangkun Zhang, Yicheng Zhang, Tongcun Zhang, Jianfeng Zhou, Liang Huang
Format: Article
Language:English
Published: Wiley 2020-09-01
Series:Clinical and Translational Medicine
Online Access:https://doi.org/10.1002/ctm2.176

Internet

https://doi.org/10.1002/ctm2.176

Similar Items